• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于支气管扩张症维持治疗中靶向感染的干粉吸入剂配方

Dry Powder Inhaler Formulation of Targeting Infection in Bronchiectasis Maintenance Therapy.

作者信息

Tran The-Thien, Cheow Wean Sin, Pu Siyu, Park Jin-Won, Hadinoto Kunn

机构信息

School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University Singapore, Singapore 637459, Singapore.

Singapore Institute of Technology, Singapore 138683, Singapore.

出版信息

Pharmaceutics. 2024 Jul 25;16(8):980. doi: 10.3390/pharmaceutics16080980.

DOI:10.3390/pharmaceutics16080980
PMID:39204326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11357607/
Abstract

The inhaled delivery of lactic acid bacteria (LAB) probiotics has been demonstrated to exert therapeutic benefits to the lungs due to LAB's immunomodulatory activities. The development of inhaled probiotics formulation, however, is in its nascent stage limited to nebulized LAB. We developed a dry powder inhaler (DPI) formulation of (LGG) intended for bronchiectasis maintenance therapy by spray freeze drying (SFD). The optimal DPI formulation (i.e., LGG: mannitol: lactose: leucine = 35: 45: 15: 5 wt.%) was determined based on the aerosolization efficiency (86% emitted dose and 26% respirable fraction) and LGG cell viability post-SFD (7 log CFU/mL per mg powder). The optimal DPI formulation was evaluated and compared to lyophilized naked LGG by its (1) adhesion capacity and cytotoxicity to human lung epithelium cells (i.e., A549 and 16HBE14o- cells) as well as its (2) effectiveness in inhibiting the growth and adhesion of to lung cells. The optimal DPI of LGG exhibited similar non-cytotoxicity and adhesion capacity to lung cells to naked LGG. The DPI of LGG also inhibited the growth and adhesion of to the lung cells as effectively as the naked LGG. The present work established the feasibility of delivering the LAB probiotic by the DPI platform without adversely affecting LGG's anti- activities.

摘要

由于乳酸菌(LAB)的免疫调节活性,吸入乳酸菌益生菌已被证明对肺部具有治疗益处。然而,吸入式益生菌制剂的开发尚处于初期阶段,仅限于雾化的LAB。我们通过喷雾冷冻干燥(SFD)开发了一种用于支气管扩张维持治疗的鼠李糖乳杆菌(LGG)干粉吸入剂(DPI)制剂。基于雾化效率(86%的 emitted dose 和 26%的可吸入部分)以及喷雾冷冻干燥后 LGG 细胞活力(每毫克粉末 7 log CFU/mL)确定了最佳 DPI 制剂(即 LGG:甘露醇:乳糖:亮氨酸 = 35:45:15:5 wt.%)。通过以下方面对最佳 DPI 制剂进行评估并与冻干的裸 LGG 进行比较:(1)对人肺上皮细胞(即 A549 和 16HBE14o-细胞)的粘附能力和细胞毒性,以及(2)抑制铜绿假单胞菌对肺细胞生长和粘附的有效性。LGG 的最佳 DPI 对肺细胞表现出与裸 LGG 相似的无细胞毒性和粘附能力。LGG 的 DPI 在抑制铜绿假单胞菌对肺细胞的生长和粘附方面也与裸 LGG 一样有效。本研究确立了通过 DPI 平台递送 LAB 益生菌的可行性,且不会对 LGG 的抗菌活性产生不利影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/11357607/302c4134f0e9/pharmaceutics-16-00980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/11357607/4b50d3362ff3/pharmaceutics-16-00980-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/11357607/386349f6fc8b/pharmaceutics-16-00980-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/11357607/58b235f83722/pharmaceutics-16-00980-g0A5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/11357607/302c4134f0e9/pharmaceutics-16-00980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/11357607/4b50d3362ff3/pharmaceutics-16-00980-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/11357607/386349f6fc8b/pharmaceutics-16-00980-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/11357607/58b235f83722/pharmaceutics-16-00980-g0A5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/11357607/302c4134f0e9/pharmaceutics-16-00980-g001.jpg

相似文献

1
Dry Powder Inhaler Formulation of Targeting Infection in Bronchiectasis Maintenance Therapy.用于支气管扩张症维持治疗中靶向感染的干粉吸入剂配方
Pharmaceutics. 2024 Jul 25;16(8):980. doi: 10.3390/pharmaceutics16080980.
2
Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.用于支气管扩张症治疗的高载量抗生素纳米颗粒复合物的干粉吸入剂配方:喷雾干燥与喷雾冷冻干燥制备法
Int J Pharm. 2016 Feb 29;499(1-2):38-46. doi: 10.1016/j.ijpharm.2015.12.072. Epub 2016 Jan 3.
3
A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart.支气管扩张症的新治疗途径:环丙沙星纳米复合物干粉吸入剂在体外黏液通透性和抗菌效果方面优于其天然环丙沙星对应物。
Int J Pharm. 2018 Aug 25;547(1-2):368-376. doi: 10.1016/j.ijpharm.2018.06.017. Epub 2018 Jun 7.
4
Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.单独药物和基于载体的 GLP-1 干粉吸入剂制剂的开发。
Int J Pharm. 2022 Apr 5;617:121601. doi: 10.1016/j.ijpharm.2022.121601. Epub 2022 Feb 16.
5
Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.开发可吸入透明质酸/甘露醇复合干粉用于氟胞嘧啶重新定位治疗肺部感染的局部治疗。
J Control Release. 2016 Sep 28;238:80-91. doi: 10.1016/j.jconrel.2016.07.029. Epub 2016 Jul 19.
6
Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.利福平干粉吸入剂的配方:一种用于肺泡结核病的改良靶向递药系统。
J Aerosol Med Pulm Drug Deliv. 2017 Dec;30(6):388-398. doi: 10.1089/jamp.2017.1379. Epub 2017 May 16.
7
Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates inflammatory response and homeostasis of spleen and colon in experimental model of Pseudomonas aeruginosa pneumonia.鼠李糖乳杆菌 GG 治疗可改善铜绿假单胞菌肺炎实验模型的肠道通透性,并调节脾脏和结肠的炎症反应和内稳态。
Clin Nutr. 2017 Dec;36(6):1549-1557. doi: 10.1016/j.clnu.2016.09.025. Epub 2016 Oct 1.
8
Preserving viability of Lactobacillus rhamnosus GG in vitro and in vivo by a new encapsulation system.通过一种新型包封系统在体外和体内保存鼠李糖乳杆菌GG的活力。
J Control Release. 2016 May 28;230:79-87. doi: 10.1016/j.jconrel.2016.04.009. Epub 2016 Apr 7.
9
Development of enteric polymer-based microspheres by spray-drying for colonic delivery of Lactobacillus rhamnosus GG.喷雾干燥法制备基于肠溶性聚合物的微球用于结肠递送鼠李糖乳杆菌 GG。
Int J Pharm. 2020 Jun 30;584:119414. doi: 10.1016/j.ijpharm.2020.119414. Epub 2020 May 8.
10
Mucosal adhesion and anti-inflammatory effects of GG in the human colonic mucosa: A proof-of-concept study.在人类结肠黏膜中 GG 的黏膜黏附作用和抗炎效果:一项概念验证研究。
World J Gastroenterol. 2018 Nov 7;24(41):4652-4662. doi: 10.3748/wjg.v24.i41.4652.

引用本文的文献

1
Biotherapeutic potential of different fractions of cell-free supernatants from against .来自……的无细胞上清液不同组分对……的生物治疗潜力 。 你提供的原文信息不完整,“from”和“against”后面缺少具体内容。
Front Cell Infect Microbiol. 2025 Jun 30;15:1608897. doi: 10.3389/fcimb.2025.1608897. eCollection 2025.
2
The Respiratory Tract Microbiome and Human Health.呼吸道微生物群与人类健康
Microb Biotechnol. 2025 May;18(5):e70147. doi: 10.1111/1751-7915.70147.
3
Respiratory Delivery of GG by Vibrating-Mesh and Jet Nebulisation.通过振动网式雾化器和喷射雾化器进行GG的呼吸道给药。

本文引用的文献

1
Eradication treatment for infection in adults with bronchiectasis: a systematic review and meta-analysis.成人支气管扩张症 感染的根治治疗:系统评价和荟萃分析。
Eur Respir Rev. 2024 Jan 31;33(171). doi: 10.1183/16000617.0178-2023.
2
Probiotics for the prevention and treatment of COVID-19: a rapid systematic review and meta-analysis.益生菌用于预防和治疗新型冠状病毒肺炎:一项快速系统评价和荟萃分析
Front Nutr. 2023 Oct 27;10:1274122. doi: 10.3389/fnut.2023.1274122. eCollection 2023.
3
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa.
Pharmaceutics. 2024 Oct 14;16(10):1326. doi: 10.3390/pharmaceutics16101326.
含具有抗铜绿假单胞菌活性的乳酸菌的吸入性粉末的研制。
Int J Antimicrob Agents. 2024 Jan;63(1):107001. doi: 10.1016/j.ijantimicag.2023.107001. Epub 2023 Oct 13.
4
Probiotic Strains Differ in Their Ability to Adhere to Human Lung Epithelial Cells and to Prevent Adhesion of Clinical Isolates of from Cystic Fibrosis Lung.益生菌菌株在黏附人肺上皮细胞以及预防囊性纤维化肺临床分离株黏附的能力上存在差异。
Microorganisms. 2023 Jun 29;11(7):1707. doi: 10.3390/microorganisms11071707.
5
Lung Microbiota: Its Relationship to Respiratory System Diseases and Approaches for Lung-Targeted Probiotic Bacteria Delivery.肺部微生物组:与呼吸系统疾病的关系以及肺部靶向益生菌递送方法。
Mol Pharm. 2023 Jul 3;20(7):3320-3337. doi: 10.1021/acs.molpharmaceut.3c00323. Epub 2023 Jun 21.
6
Immunomodulatory effects of probiotic supplementation in patients with asthma: a randomized, double-blind, placebo-controlled trial.补充益生菌对哮喘患者的免疫调节作用:一项随机、双盲、安慰剂对照试验。
Allergy Asthma Clin Immunol. 2023 Jan 2;19(1):1. doi: 10.1186/s13223-022-00753-4.
7
Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery.喷雾冷冻干燥生物制剂:综述及吸入给药应用。
Pharm Res. 2023 May;40(5):1115-1140. doi: 10.1007/s11095-022-03442-4. Epub 2022 Dec 1.
8
The Beneficial Role of Probiotic in Respiratory Diseases.益生菌在呼吸系统疾病中的有益作用。
Front Immunol. 2022 May 31;13:908010. doi: 10.3389/fimmu.2022.908010. eCollection 2022.
9
The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis.MTT assay:在批量和单细胞分析中的应用、局限性、陷阱和解释。
Int J Mol Sci. 2021 Nov 26;22(23):12827. doi: 10.3390/ijms222312827.
10
Challenges associated with spray drying of lactic acid bacteria: Understanding cell viability loss.乳酸菌喷雾干燥相关挑战:理解细胞活力丧失
Compr Rev Food Sci Food Saf. 2021 Jul;20(4):3267-3283. doi: 10.1111/1541-4337.12774. Epub 2021 Jun 19.